1 completed, 1 terminated, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow danusertib: new trials by email Literature Review of danusertib trials Research Report on danusertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PHA-739358 for the Treatment of Multiple Myeloma PHA-739358 - Multiple Myeloma | Phase 2 | Terminated | Nerviano Medical Sciences | 7 | 2008-10-01 | 2014-05-28 |
| PHA-739358 for Treatment of Hormone Refractory Prostate Cancer PHA-739358 - Metastatic Hormone Refractory Prostate Cancer | Phase 2 | Completed | Nerviano Medical Sciences | 118 | 2007-09-01 | 2014-05-28 |
| PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy danusertib, laboratory biomarker analysis, pharmacological study - Leukemia | Phase 2 | Unknown | Jonsson Comprehensive Cancer Center | 16 | 2007-03-01 | 2013-12-18 |
Blast Crisis (1) · Leukemia (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Chronic-Phase (1) · Multiple Myeloma (1)
Nerviano Medical Sciences (2) · Jonsson Comprehensive Cancer Center (1)
United States (2) · France (1) · Italy (1)